Skip to main content
. 2019 Apr 17;9:6212. doi: 10.1038/s41598-019-42707-8

Figure 1.

Figure 1

PKM2 expression and clinical implication in ulcerative colitis (UC) and colorectal cancer (CRC). (a) Venn diagram of genes showing significant differential expression between normal and UC tissue in three different patient cohorts. A univariate test (two-sample t-test) with a multivariate permutation test (10,000 random permutations) was employed. In each comparison, a cut-off p-value of <0.001 was applied to retain genes with an expression level that differed significantly between the two groups of tissues examined. Expression of 893 genes was commonly up- or down-regulated in all three cohorts. (b) Genes involved in inflammation and metabolism are highlighted in bold text. (c) PKM gene expression from multiple CRC patient cohorts. P-values show significance of expression between two groups. (d) Indicated CRC patient cohorts were dichotomized by relatively high or low PKM gene expression using the best cutoff-based on median values and then used for plotting. (e) Immunohistochemistry staining of PKM2 in normal (left), UC (middle), and CRC (right) patients. Original magnification, x200. (f) Scatter plots and correlation of Lgr5 and PKM gene expression from indicated CRC cohorts. Data represent mean ± s.d. of indicated samples. Student’s t-test was used to examine statistical significance.